Clinical Trials Directory

Trials / Unknown

UnknownNCT05861063

The Efficacy and Safety of Dezocine Pretreatment for Pain Relief in Acne Scar Treatment of Fractional CO2 Laser

The Efficacy and Safety of Dezocine Pretreatment for Pain Relief in Acne Scar

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
105 (estimated)
Sponsor
Xijing Hospital · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

The Efficacy and Safety of Dezocine Pretreatment for Pain Relief in Acne Scar Treatment of Fractional CO2 Laser

Conditions

Interventions

TypeNameDescription
DEVICEFractional CO2 laserAll patients were given oral administration of 0.5mg paronosetron hydrochloride and lidocaine cream 1 hour before surgery. After cleaning and disinfection, fractional CO2 laser treatment was given. Among them, the fractional CO2 laser laser (American Medical Laser company) selected relatively constant energy parameters in the treatment
DRUGDezocineDesocine injection was injected intravenously half an hour before surgery (10ml normal saline was added for more than 30 seconds)

Timeline

Start date
2023-02-11
Primary completion
2023-12-30
Completion
2024-12-31
First posted
2023-05-16
Last updated
2023-05-16

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05861063. Inclusion in this directory is not an endorsement.